Experiment 485261
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV |
| Organism | Empty organism |
| Citation | BISSETT,D: KAYE,SB:. (1993). TAXOL AND TAXOTERE. CURRENT STATUS AND FUTURE PROSPECTS.. 29(9) |
| Amount utilized | |
| Compound isolated | |
| Disease | PHASE I STUDIES SHOW NEUTROPENIA MYCOSITIS, HYPERSENSITIVITY, ALOPECIA, EMESIS, PRURITIS, PERIPHERAL EDEMA AND PLEURAL THICKENING. ACTIVE AGAINST OVARIAN AND BREAST CANCER. |
| Dose amount | 110.0 MG |
| Number | 6 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | SQ M BODY SURFACE |
| Dose expression | MAXIMUM TOLERATED DOSE |